Bacterial antibiotic resistance before and after clinical application in the United States.
- 1 April 1987
- journal article
- research article
- Vol. 63 (3) , 217-30
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Activity of temocillin and ticarcillin against consecutively isolated Enterobacteriaceae in four medical centresJournal of Antimicrobial Chemotherapy, 1986
- Aztreonam: Antibacterial Activity, β-Lactamase Stability, and Interpretive Standards and Quality Control Guidelines for Disk-Diffusion Susceptibility TestsClinical Infectious Diseases, 1985
- Cefpiramide: comparative in-vitro activity and β-lactamase stabilityJournal of Antimicrobial Chemotherapy, 1985
- Imipenem (N-formimidoyl thienamycin): In vitro antimicrobial activity and β-lactamase stabilityDiagnostic Microbiology and Infectious Disease, 1985
- 3-0-demethyl fortimicin A: In vitro activity and interpretive zone standards for disk diffusion susceptibility testsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centersAntimicrobial Agents and Chemotherapy, 1984
- Transferable multiple antibiotic resistance in Haemophilus influenzaeJournal of Antimicrobial Chemotherapy, 1981
- Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycinAntimicrobial Agents and Chemotherapy, 1980
- Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicinAntimicrobial Agents and Chemotherapy, 1980